PacBio Enters Cancer Genomics Research Collaboration in Singapore with Advanced Onso Sequencing
October 11, 2024 09:05 ET
|
PacBio
SINGAPORE, Oct. 11, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the signing of a new Research...
PacBio to Report Third Quarter 2024 Financial Results on November 7, 2024
October 10, 2024 16:05 ET
|
PacBio
MENLO PARK, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2024 financial results on...
PacBio, A*STAR, and Macrogen Unveil State-of-the-Art Lab to Accelerate Genomics Innovation in Singapore
October 01, 2024 09:05 ET
|
PacBio
SINGAPORE, Oct. 01, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, in collaboration with the Agency for Science,...
PacBio Grants Equity Incentive Award to New Employee
September 27, 2024 16:05 ET
|
PacBio
MENLO PARK, Calif., Sept. 27, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation...
PacBio Announces the HiFi Solves Sub-fertility Consortium in Asia Pacific
September 11, 2024 09:05 ET
|
PacBio
SINGAPORE, Sept. 11, 2024 (GLOBE NEWSWIRE) -- The HiFi Solves Sub-fertility Consortium, an innovative collaboration involving five leading centers across the Asia-Pacific region, announces work...
Revio to Power Research in Male Infertility and Rare Disease at Münster University Hospital
September 04, 2024 09:05 ET
|
PacBio
MENLO PARK, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced a collaboration with the...
PacBio to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
August 26, 2024 16:03 ET
|
PacBio
MENLO PARK, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will...
PacBio Announces Second Quarter 2024 Financial Results
August 07, 2024 16:05 ET
|
PacBio
MENLO PARK, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2024. Second quarter results: Revenue of $36.0 million...
Singapore’s National Precision Medicine (NPM) programme will partner with PacBio to propel HiFi Sequencing in Southeast Asia
August 05, 2024 16:05 ET
|
PacBio
SINGAPORE, Aug. 05, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced that Precision Health Research, Singapore...
Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing
July 23, 2024 09:05 ET
|
PacBio
MENLO PARK, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that Novogene is using its...